Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

Xiaowen Tang; Lin Yang; Zheng Li; Ansel P Nalin; Haiping Dai; Ting Xu; Jia Yin; Fengtao You; Mingqing Zhu; Wenhong Shen; Guanghua Chen; Xiaming Zhu; Depei Wu; Jianhua Yu

Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

Am J Cancer Res. 2018 Sep 1;8(9):1899. eCollection 2018.

Authors

Xiaowen Tang^{1

2

3}, Lin Yang^{3

4

5}, Zheng Li^{1

2

3}, Ansel P Nalin⁶, Haiping Dai^{1

2

3}, Ting Xu^{1

2

3}, Jia Yin^{1

2

3}, Fengtao You^{3

4

5}, Mingqing Zhu^{1

2

3}, Wenhong Shen^{1

2

3}, Guanghua Chen^{1

2

3}, Xiaming Zhu^{1

2

3}, Depei Wu^{1

2

3}, Jianhua Yu^{6

7

8}

Affiliations

¹ The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, China.
² Institute of Blood and Bone Marrow Transplantation Suzhou, China.
³ Collaborative Innovation Center of Hematology, Soochow University Suzhou, China.
⁴ The Cyrus Tang Hematology Center, Soochow University Suzhou, China.
⁵ Persongen Biotherapeutics Co., Ltd. Suzhou, China.
⁶ Comprehensive Cancer Center, The Ohio State University Columbus, OH 43210, USA.
⁷ The James Cancer Hospital, The Ohio State University Columbus, OH 43210, USA.
⁸ Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University Columbus, OH 43210, USA.

PMID: 30323981
PMCID: PMC6176185

Abstract

[This corrects the article on p. 1083 in vol. 8, PMID: 30034945.].

Publication types

Published Erratum